Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O1IM
|
|||
| Former ID |
DNCL002141
|
|||
| Drug Name |
CC-115
|
|||
| Synonyms |
CC-115 (hydrochloride); CC-115 hydrochloride; 1300118-55-1; SCHEMBL1767621; BCP20709; HY-16962A; AKOS030526389
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1 | [1] | |
| Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 1 | [1] | ||
| Company |
Celgene
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H16N8O
|
|||
| Canonical SMILES |
CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C
|
|||
| InChI |
1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23)
|
|||
| InChIKey |
GMYLVKUGJMYTFB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1228013-15-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
15008861, 22455284, 44144352, 77529760, 99436984, 124757004, 124966544, 125163809, 125335329, 131480760, 134222632, 134964418, 136367304, 136367847, 137248109, 137750678, 143499298, 144116327, 152234784, 152258252, 152344384, 160647088, 162011464, 162037439, 162205107, 163893414, 164159505, 172131582, 172650377, 174006452, 174530327, 174530328, 180096554, 186014822, 198945474, 223704779, 226877051, 242059900, 247295286, 249565685, 249871551, 252215975, 252438951
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01353625) Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.